Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 6—June 2021
Research Letter

Evidence of Oropouche Orthobunyavirus Infection, Colombia, 2017

Figures
Article Metrics
Doris E. Gómez-CamargoComments to Author , Jorge A. Egurrola-Pedraza, Cristopher D. Cruz, Dina Popuche, Margarita M. Ochoa-Díaz, Carolina Guevara, Maria Silva, Eugenio J. Abente, and Julia S. Ampuero
Author affiliations: Universidad de Cartagena, Cartagena, Colombia (D.E. Gómez-Camargo, J.A. Egurrola-Pedraza, M.M. Ochoa-Díaz); US Naval Medical Research Unit No. 6, Lima, Peru (C.D. Cruz, D. Popuche, C. Guevara, M. Silva, E.J. Abente, J.S. Ampuero)

Cite This Article

Abstract

We describe an Oropouche orthobunyavirus infection in a women 28 years of age in Colombia. We confirmed the diagnosis by viral isolation, quantitative reverse transcription PCR, and phylogenetic analysis of the small, medium, and large genomic segments. The virus is related to a strain isolated in Ecuador in 2016.

Oropouche fever is an emerging zoonotic disease caused by Oropouche orthobunyavirus (OROV; family Peribunyaviridae, genus Orthobunyavirus). The disease was initially reported in Trinidad and Tobago in 1955; since then, researchers have documented >30 outbreaks in Brazil and Peru and isolated cases in Panama and Ecuador (1,2). OROV infection is characterized by acute febrile illness with symptoms such as headache, myalgia, arthralgia, chills, photophobia, nausea, vomiting, and dizziness. Patients with severe cases might have hemorrhaging and aseptic meningitis (1).

The OROV virion is enveloped and composed of a tripartite (segment lengths: 958 nt for small, 4,385 nt for medium, and 6,852 nt for large), negative-sense, single-stranded RNA genome (1,3,4). In 1964, Groot (5) described antibodies against OROV in serum samples from primates studied in Magdalena Medio and La Lizama (Colombia) in 1957. Since 2009, researchers have identified competent vectors such as Aedes serratus, Coquillettidia venezuelensis, and Culex quinquefasciatus mosquitoes on the Caribbean coast of Colombia (6,7). We describe an OROV infection in a woman in this region. We confirmed the diagnosis by viral isolation and reverse transcription PCR (RT-PCR).

A woman 28 years of age who did domestic work arrived at the emergency department of the E.S.E. Local Hospital of Turbaco (Turbaco, Colombia) on September 9, 2017. She had a 1-day history of fever, malaise, chills, myalgia, headache, retroocular pain, photophobia, dizziness, sore throat, anorexia, dysgeusia, and nausea. She had conjunctival injection and an axillary temperature of 38.6°C; she had no other pathologic abnormalities and tested negative on a tourniquet test. After receiving informed consent, we collected 12 mL of blood and stored the sample at −80°C.

One aliquot of serum was sent to the laboratory of the US Naval Medical Research Unit No. 6 (Lima, Peru) as part of an ongoing collaborative pathogen surveillance effort with the University of Cartagena (Cartagena, Colombia). This study protocol was approved by the Institutional Ethics Committee in Scientific Research of the University of Cartagena and the US Naval Medical Research Unit No. 6 Institutional Review Board (protocol no. NMRCD.2010.0010) in compliance with all applicable federal regulations governing the protection of human participants.

We extracted RNA from the sample; it tested negative for dengue, Zika, and chikungunya viruses by real-time RT-PCR. We inoculated the sample into Vero 76 cells using a previously described technique (8) and observed a cytopathic effect in 50%–75% of the cells at 4 days after inoculation. We conducted an indirect immunofluorescence assay with pooled polyclonal antisera against flaviviruses (yellow fever virus and dengue virus serotype 3), alphaviruses (Venezuelan equine encephalitis virus, Eastern equine encephalitis virus, and Mayaro virus), hantavirus (Sin Nombre virus), arenaviruses (Allpahuayo virus and Tacaribe virus), cardiovirus (encephalomyocarditis virus), and bunyaviruses (Guaroa virus [GROV], caraparu virus, and OROV); we detected a positive signal with the bunyavirus antisera pool. We conducted another indirect immunofluorescence assay with individual polyclonal antisera against GROV, caraparu virus, and OROV; we detected a positive signal with the OROV polyclonal antisera. The serum sample tested negative for IgM against OROV, GROV, Mayaro virus, and Tacaribe virus by ELISA with whole virus antigen produced in-house. The original clinical samples tested positive by OROV-specific RT-PCR at independent laboratories in Peru and Colombia (9).

To characterize the virus at the molecular level, we used supernatant from the viral isolation to extract, amplify, and sequence the viral genome. We amplified the complete genome of the virus using a modified protocol of sequence-independent single primer amplification (10). We used the Nextera XT DNA Library Preparation Kit (Illumina, https://www.illumina.com) to prepare a library and sequenced the samples with MiSeq Reagent kit version 3 (600-cycle) (Illumina) according to the manufacturer’s instructions.

Figure

Maximum-likelihood phylogenetic tree based on the small (A), large (B), and medium (C) segments of Oropouche orthobunyavirus from a patient in Colombia, 2017 (red text), and reference sequences. Numbers to the left of nodes indicate bootstrap values based on 1,000 replicates. GenBank accession numbers are given for representative strains used for comparison. Triangles indicate phylogenetic branches compressed for size (4,9). Faceys Paddock and Bunyamwera viruses were used as outgroups. Scale corresponds to phylogenetic distance units estimated by likelihood function model. IQTV, Iquitos virus; MdDV, Madre de Dios virus.

Figure. Maximum-likelihood phylogenetic tree based on the small (A), large (B), and medium (C) segments of Oropouche orthobunyavirus from a patient in Colombia, 2017 (red text), and reference sequences. Numbers to...

The phylogenetic analyses of the small, medium, and large segments (GenBank accession nos. MK643115–7) showed that the strain is closely related to a strain isolated in Ecuador in 2016; it also forms a clade with a strain isolated in Peru in 2008 (Figure). We cannot posit transmission dynamics across country borders without additional sequence data. The patient did not travel outside the municipality during the 15 days before symptom onset, suggesting that OROV transmission occurred in Turbaco. Aedes serratus and Culex quinquefasciatus mosquitoes, which are OROV-competent vectors, have been identified in Turbaco (E. Cano-Perez, pers. comm.).

Our findings support the diagnostic use of OROV-specific RT-PCR for patients with acute febrile illness in this region. The increased use of this diagnostic tool will help clarify levels of circulation of OROV, informing decisions about Force Health Protection of US service members. In conclusion, local transmission of Oropouche orthobunyavirus infection may be occurring in this region.

Dr. Gómez-Camargo is the director of Tropical Medicine Doctoral Program and the UNIMOL Laboratory at the Universidad de Cartagena in Cartagena, Colombia. Her primary research interest is the molecular biology of infectious diseases.

Top

Acknowledgments

We thank Ivan Diaz and Omaira Rodriguez for their support of the fieldwork and Juan Camilo Roncallo for his laboratory support.

This study was supported by funding from US Department of Defense Health Agency, Armed Forces Health Surveillance Division, Global Emerging Infections Surveillance Branch (work unit no. 800000.82000.25GB.B0016; ProMIS ID: 20160390211).

E.J.A. is US military service member. C.D.C., D.P., C.G., M.S. and J.S.A. are employees of the US government. This work was prepared as part of their official duties. Title 17, USC, §105 provides that copyright protection under this title is not available for any work of the US Government. Title 17, USC, §101 defines a US Government work as a work prepared by a military Service member or employee of the US Government as part of that person’s official duties.

Top

References

  1. Romero-Alvarez  D, Escobar  LE. Oropouche fever, an emergent disease from the Americas. Microbes Infect. 2018;20:13546. DOIPubMedGoogle Scholar
  2. Wise  EL, Pullan  ST, Márquez  S, Paz  V, Mosquera  JD, Zapata  S, et al. Isolation of Oropouche virus from febrile patient, Ecuador. Emerg Infect Dis. 2018;24:9357. DOIPubMedGoogle Scholar
  3. Sakkas  H, Bozidis  P, Franks  A, Papadopoulou  C. Oropouche fever: a review. Viruses. 2018;10:175. DOIPubMedGoogle Scholar
  4. Travassos da Rosa  JF, de Souza  WM, Pinheiro  FP, Figueiredo  ML, Cardoso  JF, Acrani  GO, et al. Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected Orthobunyavirus. Am J Trop Med Hyg. 2017;96:101930.PubMedGoogle Scholar
  5. Groot Liévano  H. Studies on arthropod-transmitted viruses in Colombia [in Spanish]. Revista de la Academia Colombiana de Ciencas Exactas, Físicas y Naturales. 2017;4:1233.
  6. Hoyos-López  R, Suaza-Vasco  J, Rúa-Uribe  G, Uribe  S, Gallego-Gómez  JC. Molecular detection of flaviviruses and alphaviruses in mosquitoes (Diptera: Culicidae) from coastal ecosystems in the Colombian Caribbean. Mem Inst Oswaldo Cruz. 2016;111:62534. DOIPubMedGoogle Scholar
  7. Parra-Henao  G, Suárez  L. Mosquitoes (Diptera: Culiciadae) as potential vectors of arboviruses in the Urabá region, Northwest of Colombia [in Spanish]. Biomedica. 2012;32:25262. DOIPubMedGoogle Scholar
  8. Forshey  BM, Guevara  C, Laguna-Torres  VA, Cespedes  M, Vargas  J, Gianella  A, et al.; NMRCD Febrile Surveillance Working Group. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis. 2010;4:e787. DOIPubMedGoogle Scholar
  9. Saeed  MF, Wang  H, Nunes  M, Vasconcelos  PFC, Weaver  SC, Shope  RE, et al. Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol. 2000;81:7438. DOIPubMedGoogle Scholar
  10. Djikeng  A, Halpin  R, Kuzmickas  R, Depasse  J, Feldblyum  J, Sengamalay  N, et al. Viral genome sequencing by random priming methods. BMC Genomics. 2008;9:5. DOIPubMedGoogle Scholar

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2706.204405

Original Publication Date: May 07, 2021

Table of Contents – Volume 27, Number 6—June 2021

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Doris E. Gómez-Camargo, calle 29 #50-50, Laboratorio UNIMOL, Universidad de Cartagena, Campus de la Salud, Cartagena, Colombia

Send To

10000 character(s) remaining.

Top

Page created: March 25, 2021
Page updated: May 18, 2021
Page reviewed: May 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external